The self-assembling peptide, our core technology, was discovered by Dr. Shuguang Zhang of the Massachusetts Institute of Technology (MIT) in the United States in 1992. The first-generation self-assembling peptide has been produced as PuraMatrix™.
The self-assembling peptide that we developed consists of an amphipathic peptide that forms nanofibers from the change in pH or the response to inorganic salts contained in solutions. At a macro level, gelatinization (self-assembling) occurs. The self-assembled peptide hydrogel maintains three-dimensional structures with nanofibers formed from the hydrophobic bond and complementary charge distribution of amino acids.
Drug Discovery Technology
Our self-assembling peptides are user-friendly injectable gels developed as carriers for sustained-release topical drug delivery systems (DDS) for a wide range of applications. In previous studies, protein stability, drug release rate adjustable by customization and the penetrability of X-Rays have been shown.